Om

Conduit Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing clinical-stage assets that address unmet medical needs. The company concentrates on therapeutic programs in autoimmune diseases and idiopathic male infertility, with research centered on conditions such as Hashimoto’s thyroiditis, uveitis, renal transplant rejection, and preterm labor. Its current pipeline includes assets such as AZD1656 and AZD5904, which are being explored for their potential applications across these treatment areas. Conduit Pharmaceuticals works at the intersection of drug development, clinical research, and asset advancement, aiming to support the progression of novel therapies through the development process. The company is headquartered in Naples, Florida.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I CDT EQUITY MED ENDAVU: Køb CDT Equity ($CDT) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i CDT Equity, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.